Unravelling the role of PRKCI and key-cancer related genes in breast cancer development and metastasis

Breast cancer metastasis
DOI: 10.1007/s12672-025-02133-x Publication Date: 2025-03-18T15:04:25Z
ABSTRACT
Breast cancer is one of the most common causes fatalities in females globally. Rising cases drug resistance against existing chemotherapeutics are great problem. To address this issue, there a need to find appropriate biomarker that could be used detect at early stages, so development can avoided. Protein Kinase C iota (PKCɩ), an AGC kinase, has oncogenic role cancers and its expression Single nucleotide polymorphisms (SNPs) have been reported associated with development. So, study aims were examine PKCɩ, B (AKT), Suppressor cytokine signaling 3 (SOCS3), Vascular endothelial growth factor (VEGF), Krupple like (KLF3), Tumor protein D52 (TPD52), Hypoxia inducible (HIF1α) microRNA-124 (miR-124) breast association PKCɩ variants (G34W & F66Y) cancer. Genetic assay was performed through real time Polymerase Chain reaction (PCR), whereas genotypic SNPs accomplished Tetra-ARMS PCR. The levels AKT, SOC3, VEGF, HIF1α TPD52 elevated patients as compared control miR-124 KLF3 lowered patients. Positive variant G34W (TT) explored ARM's PCR, while no F66Y found. Hence, results suggest related genes after further verification serve potential biomarkers for early-diagnosis prognosis
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (60)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....